期刊文献+

甲状腺乳头状癌组织中CDKN2A/p14^(ARF)蛋白表达及其临床意义

The expression of CDKN2A/p14^(ARF) protein and its′ clinical significance in papillary thyroid carcinoma
下载PDF
导出
摘要 目的通过检测CDKN2A/p14ARF蛋白在甲状腺乳头状癌组织中的表达,探讨并分析CDKN2A/p14ARF在甲状腺乳头状癌发生发展中的作用和在癌旁正常甲状腺组织与甲状腺乳头状癌之间表达的差异。方法采用免疫组织化学方法(SP法)检测甲状腺乳头状癌和癌旁正常甲状腺组织中CDKN2A/p14ARF蛋白的表达情况,并进行统计学分析。结果 CDKN2A/p14ARF在甲状腺乳头状癌组织中表达阳性率87.8%(36/41),其中阳性程度在(++)以上者20例,占48.8%(20/41)。癌旁正常甲状腺组织阳性率为75%(15/20),甲状腺乳头状癌和癌旁正常甲状腺组织之间差异有统计学意义(P<0.05)。在甲状腺乳头状癌中CDKN2A/p14ARF蛋白表达与患者性别、年龄之间的差异无统计学意义(P>0.05)。结论 CDKN2A/p14ARF在甲状腺乳头状癌中表达率极高,是甲状腺乳头状癌病理诊断中非常有价值的辅助诊断指标。 Objective Throughout testing the immunohistochemic expression of CDKN2A/p14ARF in the papillary thyroid carcinoma tissue,to explore the protein function during the development of the papillary thyroid carcinoma.To analyze the different expressions between the para-tumor normal tissues and the papillary thyroid carcinoma.Methods Immunohistochemistry(S-P method) was esed to find out the expression of CDKN2A/p14ARF in the papillary thyroid carcinoma and para-tumor normal tissues.At the same time,the statistics way was used to analyze.Results CDKN2A/p14ARF positive rate was 87.8%(36/41)in the expression of the papillary thyroid carcinoma,20 cases reached a degree above(++),accounting for 48.8%(20/41).The positive rate of para-tumor normal tissues was 75%(15/20).Compared to the papillary thyroid carcinoma and para-tumor normal tissues of thyroid gland pathologically,the difference was higher(P0.05).The expression of CDKN2A/p14ARF did not have obvious dependablity with the sex or age were not statistically significant(P0.05).Conclusion CDKN2A/p14ARF have an extremely high expression rate in the papillary thyroid carcinoma,which is remarkably valuable assistant diagnostic points in the pathological diagnosis text.
出处 《新疆医科大学学报》 CAS 2011年第5期466-469,共4页 Journal of Xinjiang Medical University
基金 国家自然科学基金(30860275)
关键词 甲状腺乳头状癌 CDKN2A/p14ARF 免疫组织化学 papillary thyroid carcinoma CDKN2A/p14ARF immunohistochemistry
  • 相关文献

参考文献12

  • 1哈斯也提.木明,尼加提.热合木,张丽.Galectin-3、CD44v6在滤泡上皮起源甲状腺肿瘤中的表达及意义[J].新疆医科大学学报,2009,32(7):867-869. 被引量:3
  • 2Witt RL.Initial surgical management of thyroid cancer[J].Surg Oncol Clin N Am,2008,17(1):71-91. 被引量:1
  • 3杨曦,阿仙姑.哈斯木,韶峰,武爽,阿布力孜.阿布杜拉,夏米西努尔.伊力克.新疆地区甲状腺癌组织中ESR1基因表达及其临床意义的探讨[J].癌变.畸变.突变,2010,22(3):214-217. 被引量:5
  • 4Wolter M,Reifenberger J,Blaschke B,et al.Oligodendroglial tumors frequently demonstrate hypermetylation of the CDKN2A,P14ARF and CDKN2B tumor suppressor genes[J].J Neuropathol Exp Neurol,2001,60(12):1170-1180. 被引量:1
  • 5赵国海,李铁臣,史良会,夏亚斌,孙惠兰,彭敦发.胃癌中p16基因缺失与突变的研究[J].中国病理生理杂志,2002,18(5):543-545. 被引量:13
  • 6Tannapfel A,Busse C,Weinans L,et al.INK4a-ARF alterations and P53 mutations in hepatocellular carcinomas[J].Oncogene,2001,20(48):7104-7109. 被引量:1
  • 7Korshunov A,Golanov A,Timirgaz V,et al.p14ARF protein immunoreactivity in intracranial ependymomas and its prognostic significance:an analysis of 103 cases[J].Acta Neuropathal,2001,102(3):271-277. 被引量:1
  • 8Manel Esteller,Caros Cordon-Cardo,Paul G,et al.p14ARF silencing by promotor hypermethylation mediates abnormal intracellur localization of MDM2[J].Cancer Res,2001,61(7):2816-2812. 被引量:1
  • 9Lev BOR,Maya R,Seqel LA.Generation of oscilations by the p53-MDM2 feedback loop:a theoretical and experimental study[J].Proc Natl Acad Sci USA,2000,97(21):11250-11255. 被引量:1
  • 10Schmidt EE,Ichimura K,Messerle KR,et al.Infrequent methylation of CDKN2A and rare mutation of both CDKN2A and CDKN2B in primary astrocytic tumours[J].Cancer,1997,75(1):2-8. 被引量:1

二级参考文献17

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部